Summer Jensen
About Summer Jensen
Summer Jensen serves as the Director of Business Development at Celerion, where she has worked since 2014. She has extensive experience in early stage clinical development and a strong background in clinical conduct, bioanalytical services, and regulatory affairs.
Current Role at Celerion
Summer Jensen serves as the Director of Business Development at Celerion, a position she has held since 2014. In this role, she focuses on expanding business opportunities within the organization, particularly in Phase 1 sites and clinical development services. Her responsibilities include leveraging her extensive knowledge of bioanalytical services and clinical conduct to drive growth and enhance service offerings.
Previous Experience at PRA International
Prior to her tenure at Celerion, Summer Jensen worked at PRA International, formerly known as CRI Lifetree, as an Account Director for Early Development Services from 2013 to 2014. During her one-year term, she managed client accounts and contributed to the development of early-stage clinical services, enhancing her expertise in the clinical research field.
Career Background at Radiant Research
Summer Jensen's career includes a significant role at Radiant Research, where she served as the Manager of Clinical Services from 1999 to 2008. Over the course of nine years, she gained valuable experience in clinical operations, which laid the foundation for her future roles in business development and clinical research management.
Education and Expertise
Summer Jensen studied at Montana State University - Bozeman from 1992 to 1997, where she acquired foundational knowledge that supports her career in clinical development. Her education, combined with nearly 50 years of expertise at Celerion, has equipped her with a comprehensive understanding of protocol design, data management, and regulatory affairs.
Achievements in Business Development
With nearly a decade of experience in business development at Celerion, Summer Jensen has played a key role in promoting the company's clinical development services and bioanalytical capabilities. Her efforts have contributed to the organization's reputation and success in the early-stage clinical development sector.